4-(5-Bromo-2-chlorobenzyl)phenyl ethyl ether CAS NO.461432-23-5

Customized synthesis, synthetic process development of APIs, synthesis of APIs and intermediates at preclinical and clinical scale, scale-up of existing process, technology transfer and technical service are core businesses of Caerulum Pharma Discovery. APIs and intermediates projects which have covered diabetes, cancer, cardiovascular and other therapeutic areas have been completed. We will provide you with better service, better quality, better price.